Although the identification of conolidine as a potential novel analgesic agent delivers an additional avenue to address the opioid crisis and manage CNCP, even further scientific tests are required to be familiar with its mechanism of motion and utility and efficacy in managing CNCP.By binding to ACKR3, conolidine is assumed to inhibit this scaveng